Abstracts

Efficacy and Safety of endTB Regimens for Fluoroquinolone-Susceptible RR-TB in People With HIV

Background: endTB (NCT02754765) was an open-label Phase 3 randomized, controlled clinical trial to evaluate the efficacy and safety of five 9-month, all-oral regimens for fluoroquinolone-susceptible rifampin-resistant TB, compared to the WHO-recommended standard of care, in people 15 years of age or older. In the primary analysis, three experimental regimens (9BLMZ, 9BCLLfxZ, and 9BDLLfxZ) had noninferior…

Plasma Thrombomodulin Predicts Thrombotic Events & Mortality in Patients Hospitalized With COVID-19

Background: Plasma concentration of soluble thrombomodulin (sTM) is a marker of endothelial damage, and its elevation has been linked to cardiovascular diseases. The study aims to evaluate the predictive potential of sTM for thrombotic events, one of the most serious complications of COVID-19. Methods: Nested case-control study within a large cohort of hospitalized COVID-19 patients…

SARS-CoV-2 Infection and Hospitalization in Immunocompromised Children: A Population-Based Study

Background: The burden of SARS-CoV-2 infection in immunocompromised children remains unclear due to limited population-based studies. We aimed to assess the incidence of SARS-CoV-2 infection and hospitalization in children with and without immunocompromising conditions. Methods: We conducted a population-based cohort study of children aged 0-14 years in the Veneto region, Italy, from February 2020-May 2023.…

Characteristics and Outcomes of Patients with Kidney Transplant Hospitalized for COVID-19 in the US

Background: Immunocompromising conditions and advanced renal dysfunction are individually risk factors for adverse outcomes from COVID-19. We explored the intersection of these risk factors by examining variations in treatment patterns and mortality among hospitalized COVID-19 patients with a history of kidney transplant. Methods: Patients with a history of kidney transplant (ICD-10-CM: Z94.0) hospitalized in the…

Immunosuppressive Conditions Are Associated With Poor Outcomes in Patients Hospitalized for COVID-19

Background: Immunosuppressed adults (primary immunodeficiency (PI), HIV (unsuppressed and poor immune recovery), and solid organ transplant) are more likely to have severe COVID-19 and poor outcomes. Less is known about outcomes of severe COVID-19 for adults with specific immunosuppressive conditions compared to immunocompetent adults. We hypothesized that outcomes for adults with certain immunosuppressive conditions hospitalized…

COVID-19 Vaccine Protection Against Long COVID: A Population-Based Cohort Study

Background: Vaccination before SARS-CoV-2 infection might confer partial protection against the development of post-COVID conditions (‘long COVID’) compared to unvaccinated individuals. However, evidence is limited in this regard. This study aims to systematically investigate the association between different vaccination status on a series of long COVID conditions by organ system. Methods: We identified COVID-19 positive…

Characterization of Circulating Biomarkers Levels in Participants With Long COVID

Background: Post-acute sequelae of COVID19 or ‘Long COVID’ is a common but heterogenous condition associated with significant morbidity. Its pathogenesis remains poorly understood, with a number of different clinical phenotypes reported. We aimed to characterize host inflammatory responses by identifying inflammatory patterns and their association with demographic factors, comorbidities, and symptoms. Methods: In plasma from…